ABOUT US
ABOUT US

Zennova Pharmaceuticals Group is a high-tech international pharmaceutical group company registered in Cayman and driven by innovative research and development. Powered by leading product development and patented technology , we provide patients with innovative products with superior value. The company focuses on three major strategical directions:global based product development, market to global markets, State-of-The-Art manufacturing.  At present, there are many innovative preparations, and clinical works have been carried out in China and the United States.


At present, Zennova has  research and development centers in New York, USA and Chengdu, China.Zennova’s manufacturing site in Chengdu China is designed and built for qualifying US FDA CGMP ,European EMA certification and China’s GMP qualifications.  This State-of-The-Art facility aims the top global quality standard, and will produce all-dosage drugs  , including a variety of anti-tumor drugs, sterile eye drops, central nervous system drugs and other prescription drugs. All products will be sold to China and the global market.


We focus on research & development, production and market  of innovative & high quality drugs. Zennova also actively acquire featured products in the global regulated markets and   cooperate with global  leading companies for Contract Development & Manufacturing collaborations. It covers all aspects of pharmaceutical product development and commercial production.

Science & technology, based on patented innovative technology for high barrier complex formulations

Carrying out global CDMO business with American pharmaceutical technology and top global quality standards

STRATEGY

Seeking cooperation and developing innovative new drugs

VALUE:innovation , Responsibility, integrity, and win-win

MISSION:Produce innovate & high quality medicines for human health

BELIEF:Technology driven  , excellent quality
VISSION:Be a world-class pharmaceutical company operating globally

CULTURE
SLOGAN Zennova Pharma Group, Innovation For Better Medicine

MANAGMENT TEAM

Adam Feng,Ph.D

Chief Scientist

Yali Li,B.S.

General Manager

Malcolm Rosentha,MBA

Vice President of BD